AACR Annual Meeting 2026

Why Choose Avance Clinical for Oncology Clinical Trials?

As a specialist oncology Contract Research Organization (CRO) with deep global and Early Phase experience, we bring unique strengths to your drug development journey:

• Over 100 oncology trials conducted in the past five years alone, demonstrating our operational depth and a focus on cancer research.
• A dedicated Oncology Center of Excellence, combining indication-level scientific leadership, advanced Early Phase trial design, and oncology-focused site networks to support confident progression from first-in-human through Phase II.
• A complete service offering from Phase I/early-phase through to Phase II+ / late-phase, supported by our GlobalReady capability spanning Australia, Asia, and North America.
• Targeted expertise across a broad range of tumor types including hematological malignancies, solid tumors (NSCLC, melanoma, ovarian, glioblastoma) and rare oncology indications.
• Strategic geographic footprint: leveraging Australia’s efficient start-up environment and research rebate ecosystem, expanded U.S. execution and strong presence in Asia for global enrollment — making us the ideal partner for seamless multi-region oncology programs.

Let’s Connect

At AACR you’ll have the opportunity to meet Dr. George Peoples, the Executive Medical Director of the Oncology Center of Excellence. We’d love to schedule time with you at AACR to discuss your oncology portfolio and how we can support your next milestone. Book a meeting in advance to set up a dedicated discussion.

We look forward to seeing you at the AACR Annual Meeting — and helping you bring your next oncology therapeutic to the next stage.